{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:51:26Z","timestamp":1776167486537,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009882","name":"Lombardy Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jcf.2026.03.005","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:25:57Z","timestamp":1773937557000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter survey"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2315-5737","authenticated-orcid":false,"given":"Andrea","family":"Gramegna","sequence":"first","affiliation":[]},{"given":"Carlo","family":"Magnoni","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7619-8913","authenticated-orcid":false,"given":"Chiara","family":"Premuda","sequence":"additional","affiliation":[]},{"given":"Gianfranco","family":"Alicandro","sequence":"additional","affiliation":[]},{"given":"Onno","family":"Akkerman","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0357-8900","authenticated-orcid":false,"given":"Adelina","family":"Amorim","sequence":"additional","affiliation":[]},{"given":"Pilar","family":"Azevedo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2370-6551","authenticated-orcid":false,"given":"Stephen","family":"Bourke","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4246-6883","authenticated-orcid":false,"given":"Vincenzo","family":"Carnovale","sequence":"additional","affiliation":[]},{"given":"Filia","family":"Diamantea","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5036-4457","authenticated-orcid":false,"given":"Libor","family":"Fila","sequence":"additional","affiliation":[]},{"given":"Freddy","family":"Frost","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7094-0848","authenticated-orcid":false,"given":"Rosa Maria","family":"Giron Moreno","sequence":"additional","affiliation":[]},{"given":"Camelia","family":"Pescaru","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Polverino","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-0818","authenticated-orcid":false,"given":"Almudena","family":"Felipe Montiel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-3827","authenticated-orcid":false,"given":"Marta","family":"Rachel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8168-742X","authenticated-orcid":false,"given":"Gergana Petrova","family":"Stoyanova","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7242-0747","authenticated-orcid":false,"given":"Eva","family":"Van Braeckel","sequence":"additional","affiliation":[]},{"given":"Sonia","family":"Volpi","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1522-3325","authenticated-orcid":false,"given":"Andrea","family":"Vuki\u0107 -Dugac","sequence":"additional","affiliation":[]},{"given":"Sabine","family":"Wege","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1705-4780","authenticated-orcid":false,"given":"Nicholas J.","family":"Simmonds","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4611-6768","authenticated-orcid":false,"given":"Barry J.","family":"Plant","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6471-549X","authenticated-orcid":false,"given":"Damian G.","family":"Downey","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-4238","authenticated-orcid":false,"given":"Silke","family":"van Koningsbruggen-Rietschel","sequence":"additional","affiliation":[]},{"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2285-9970","authenticated-orcid":false,"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jcf.2026.03.005_bib0001","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"10212","key":"10.1016\/j.jcf.2026.03.005_bib0002","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.005_bib0003","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.202011-4153OC","article-title":"Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease","volume":"204","author":"Burgel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.005_bib0004","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1513\/AnnalsATS.202312-1065OC","article-title":"Participating Investigators of the French Cystic Fibrosis Reference Network Study Group. Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease","volume":"21","author":"Burgel","year":"2024","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.005_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.202109-2121LE","article-title":"Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France","volume":"205","author":"Martin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.005_bib0006","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcf.2024.10.006","article-title":"Factors associated with prescription of elexacaftor\/tezacaftor\/ivacaftor among people with cystic fibrosis aged 12 years or older with at least one F508del allele","volume":"24","author":"Hergenroeder","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.005_bib0007","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00236-2021","article-title":"Sensitive markers to detect progression of lung disease in children with cystic fibrosis","volume":"58","author":"Stahl","year":"2021","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.jcf.2026.03.005_bib0008","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1089\/jwh.2014.4985","article-title":"Gender differences in outcomes of patients with cystic fibrosis","volume":"23","author":"Harness-Brumley","year":"2014","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.005_bib0009","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcf.2025.04.001","article-title":"Mind the gap\"- will we ever see equal median predicted survival for males and females in cystic fibrosis?","volume":"24","author":"Duckers","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"25","key":"10.1016\/j.jcf.2026.03.005_bib0010","first-page":"01530","article-title":"Treatment decision-making for using CFTR modulator therapy in patients with cystic fibrosis","volume":"S1569-1993","author":"Carr","year":"2025","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.005_bib0011","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/212273s004lbl.pdf."},{"key":"10.1016\/j.jcf.2026.03.005_bib0012","unstructured":"https:\/\/www.ema.europa.eu\/en\/news\/combination-cystic-fibrosis-medicines-treat-patients-rare-mutations."},{"issue":"5","key":"10.1016\/j.jcf.2026.03.005_bib0013","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jcf.2022.04.020","article-title":"Clinical outcomes of a large cohort of individuals with the F508del\/5T;TG12 CFTR genotype","volume":"21","author":"Tosco","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.005_bib0014","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jcf.2024.03.008","article-title":"Sermet-Gaudelus I, Castellani C; ECFS Diagnostic Network Working Group. ECFS standards of care on CFTR-related disorders: identification and care of the disorders","volume":"23","author":"Simmonds","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.005_bib0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17476348.2016.1177460","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches","volume":"10","author":"Lund-Palau","year":"2016","journal-title":"Expert Rev Respir Med"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.005_bib0016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.005_bib0017","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0039-1698464","article-title":"Microbiology of Cystic Fibrosis Airway Disease","volume":"40","author":"Blanchard","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2026.03.005_bib0018","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.005_bib0019","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1055\/s-0039-1697975","article-title":"Acute Pulmonary Exacerbations in Cystic Fibrosis","volume":"40","author":"Goss","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.005_bib0020","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1164\/rccm.202406-1128RL","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis","volume":"210","author":"Morgan","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"10.1016\/j.jcf.2026.03.005_bib0021","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.2010.791","article-title":"Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis","volume":"303","author":"Dasenbrook","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.005_bib0022","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpeds.2004.02.038","article-title":"High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests","volume":"145","author":"Brody","year":"2004","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.005_bib0023","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.chest.2024.03.033","article-title":"Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor\/Tezacaftor\/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease","volume":"166","author":"Gramegna","year":"2024","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.005_bib0024","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12931-023-02451-0","article-title":"Heterogeneity of weight gain after initiation of Elexacaftor\/Tezacaftor\/Ivacaftor in people with cystic fibrosis","volume":"24","author":"Gramegna","year":"2023","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.005_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.27393","article-title":"Mental Health of Pediatric Patients with Cystic Fibrosis after 18 Months on Elexacaftor-Tezacaftor-Ivacaftor Therapy","volume":"60","author":"Pasley","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.03.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221144211","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on depression and anxiety in cystic fibrosis","volume":"16","author":"Zhang","year":"2022","journal-title":"Ther Adv Respir Dis"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.005_bib0027","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jcf.2024.06.010","article-title":"Wellness in the modulator era: an observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis","volume":"24","author":"Van Citters","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.005_bib0028","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/rccm.202308-1525OC","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor Treatment and Depression-related Events","volume":"209","author":"Ramsey","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.005_bib0029","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jcf.2013.11.002","article-title":"Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis","volume":"13","author":"Horsley","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.005_bib0030","article-title":"Airway clearance techniques compared to no airway clearance techniques for cystic fibrosis","volume":"4","author":"Warnock","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.005_bib0031","article-title":"Nebulised hypertonic saline for cystic fibrosis","volume":"6","author":"Wark","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.005_bib0032","first-page":"680","article-title":"Pulmonary Clinical Practice Guidelines Committee. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health","volume":"187","author":"Jr","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.005_bib0033","article-title":"Short-acting inhaled bronchodilators for cystic fibrosis","volume":"6","author":"Smith","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2026.03.005_bib0034","article-title":"Assessing Shared Decision-Making in Cystic Fibrosis Care Using collaboRATE: a Cross-Sectional Study of 159 Programs","volume":"8","author":"Homa","year":"2021","journal-title":"J Patient Exp"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.005_bib0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2024.05.007","article-title":"Standards for the care of people with cystic fibrosis (CF); Planning for a longer life","volume":"23","author":"Gramegna","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.005_bib0036","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2021.07.019","article-title":"Pregnancy in cystic fibrosis: review of the literature and expert recommendations","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.005_bib0037","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2024.01.012","article-title":"ECFS standards of care on CFTR-related disorders: towards a comprehensive program for affected individuals","volume":"23","author":"De Wachter","year":"2024","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:56:36Z","timestamp":1776164196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"alternative-id":["S1569199326000500"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}